EGFR/HER2-IN-6 (compound 43) is a dual EGFR/HER2 and DHFR inhibitor with potent activity against EGFR kinase, HER2 kinase, and DHFR, characterized by IC50 values of 0.122 µM, 0.078 µM, and 0.585 µM, respectively. This compound displays notable anticancer properties in various cancer cell lines, while demonstrating a favorable safety profile and selectivity indices. Consequently, EGFR/HER2-IN-6 holds promise as a valuable tool in cancer research [1].
Molecular Weight:
387.46
Formula:
C18H21N5O3S
Target:
Others|||Apoptosis|||EGFR
* VAT and and shipping costs not included. Errors and price changes excepted
